General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Alnylam(MODEST), Pfizer(MODEST), Eidos(MODEST), Eidos(MODEST), AstraZeneca Pharmaceuticals(MODEST) RESEARCH/RESEARCH GRANTS: Eidos(NONE), Pfizer Inc(SIGNIFICANT)

View Full Disclosure